Contribution of immunoglobulin lambda light chain gene rearrangement analysis in the diagnosis of B-cell neoplasms

Br J Haematol. 2019 Apr;185(2):261-265. doi: 10.1111/bjh.15762. Epub 2019 Jan 25.

Abstract

Identification of clonal IGH, IGK and IGL gene rearrangements offers diagnostic adjunct in suspected B-cell neoplasms. However, many centres omit IGL analysis as its value is uncertain. A review of 567 cases with IGH, IGK and IGL rearrangement assessed using BIOMED-2 assays showed clonal immunoglobulin gene rearrangement in 54% of cases, of which 24% had a clonal IGL rearrangement. In two cases, the clonal rearrangement was detected exclusively by IGL analysis. This finding demonstrates the added value of IGL analysis for clonality assessment, especially in suspected B-cell neoplasms in which a clonal IGH and/or IGK rearrangement is not detected or is equivocal.

Keywords: B-cell neoplasm; BIOMED-2 PCR assays; EuroClonality; IGL rearrangement; clonality analysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Female
  • Gene Rearrangement, B-Lymphocyte, Light Chain*
  • Genes, Immunoglobulin Light Chain / genetics*
  • Genes, Neoplasm
  • Humans
  • Immunoglobulin Heavy Chains / genetics
  • Immunoglobulin kappa-Chains / genetics
  • Immunoglobulin lambda-Chains / genetics*
  • Lymphoma, B-Cell / diagnosis*
  • Lymphoma, B-Cell / genetics*
  • Lymphoma, B-Cell / pathology
  • Neoplasm Grading
  • Neoplastic Stem Cells / pathology
  • Polymerase Chain Reaction / methods

Substances

  • Immunoglobulin Heavy Chains
  • Immunoglobulin kappa-Chains
  • Immunoglobulin lambda-Chains